Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66,505,186
-
Total 13F shares
-
53,596,381
-
Share change
-
+90,902
-
Total reported value
-
$105,311,940
-
Put/Call ratio
-
3.9%
-
Price per share
-
$1.75
-
Number of holders
-
74
-
Value change
-
+$3,105,761
-
Number of buys
-
30
-
Number of sells
-
34
Institutional Holders of Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS) as of Q1 2025
As of 31 Mar 2025,
Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,596,381 shares.
The largest 10 holders included
FEDERATED HERMES, INC., NEA Management Company, LLC, Octagon Capital Advisors LP, BlackRock, Inc., VANGUARD GROUP INC, Deep Track Capital, LP, Vivo Capital, LLC, BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.